common
caus
acut
exacerb
chronic
obstruct
pulmonari
diseas
aecopd
respiratori
infect
studi
bacteri
viral
caus
aecopd
conduct
western
countri
investig
bacteri
viral
identif
rate
aecopd
korea
review
analyz
medic
record
case
aecopd
korea
univers
guro
hospit
analyz
bacteri
viral
identif
rate
classifi
infect
accord
epidemiolog
factor
global
initi
chronic
obstruct
lung
diseas
stage
mortal
season
variat
result
number
aecopd
event
involv
bacteri
identif
viral
identif
bacterialvir
coidentif
identif
respect
common
infecti
bacteria
identifi
pseudomona
aeruginosa
streptococcu
pneumonia
haemophilu
influenza
common
virus
identifi
influenza
viru
rhinoviru
parainfluenza
viru
metapneumoviru
bacteri
identif
rate
tend
higher
advanc
stage
chronic
obstruct
pulmonari
diseas
overal
p
aeruginosa
pneumonia
staphylococcu
aureu
klebsiella
pneumonia
identifi
mortal
group
aureu
k
pneumonia
virus
season
ie
greater
preval
particular
season
p
influenza
viru
rhinoviru
mainli
identifi
winter
parainfluenza
viru
summer
metapneumoviru
spring
conclus
inform
epidemiolog
respiratori
infect
aecopd
improv
manag
aecopd
use
antibiot
treatment
korea
chronic
obstruct
pulmonari
diseas
copd
obstruct
lung
diseas
caus
smoke
air
pollut
copd
patient
often
experi
sudden
aggrav
respiratori
symptom
call
acut
exacerb
copd
aecopd
requir
addit
treatment
aecopd
lead
deterior
qualiti
life
substanti
morbid
mortal
major
caus
aecopd
bacteri
viral
infect
bacteri
viral
infect
region
variabl
epidemiolog
characterist
consid
treatment
howev
previou
analys
bacteri
viral
identif
rate
aecopd
conduct
western
countri
studi
asia
scarc
unclear
purpos
studi
retrospect
analyz
bacteri
viral
identif
rate
aecopd
korea
base
epidemiolog
factor
review
analyz
medic
record
case
sever
aecopd
korea
univers
guro
hospit
januari
may
search
electron
medic
record
databas
use
keyword
chronic
obstruct
pulmonari
diseas
acut
exacerb
studi
approv
institut
review
board
korea
univers
guro
hospit
approv
number
copd
diagnos
base
guidelin
global
initi
chronic
obstruct
lung
diseas
gold
aecopd
defin
acut
event
character
worsen
patient
respiratori
symptom
beyond
normal
daytoday
variat
lead
chang
medic
patient
previou
pulmonari
function
test
ratio
forc
expiratori
volum
one
second
forc
vital
capac
fvc
patient
year
old
patient
exclud
caus
admiss
someth
aecopd
heart
failur
arrhythmia
acut
pulmonari
edema
acut
pulmonari
embol
pneumothorax
comorbid
affect
immun
cancer
autoimmun
diseas
laboratori
cultur
test
conduct
within
hr
hospit
exhibit
mild
moder
exacerb
copd
cultur
antigen
detect
assay
polymeras
chain
reaction
pcr
assay
blood
sputum
urin
nasoor
oropharyng
swab
sampl
obtain
physician
within
hr
admiss
bacteri
cultur
perform
blood
sputum
sampl
use
standard
techniqu
urinari
antigen
test
perform
detect
streptococcu
pneumonia
realtim
pcr
rtpcr
assay
perform
use
nasoor
oropharyng
swab
sampl
detect
follow
respiratori
virus
influenza
viru
respiratori
syncyti
viru
parainfluenza
viru
coronaviru
rhinoviru
enteroviru
adenoviru
bocaviru
metapneumoviru
rapid
antigen
test
use
test
detect
influenza
bacteri
pathogen
determin
present
gramposit
gramneg
bacteria
detect
blood
sputum
sampl
streptococcu
pneumonia
detect
urin
antigen
detect
assay
viral
pathogen
determin
present
one
virus
list
detect
nasoor
oropharyng
swab
rtpcr
assay
influenza
viru
detect
rapid
antigen
test
data
analyz
use
spss
softwar
ibm
corp
armonk
ny
usa
data
present
deviat
number
percent
group
event
classifi
gold
stage
month
use
oneway
analysi
varianc
event
classifi
inhospit
mortal
chisquar
test
fisher
test
use
discret
data
independ
ttest
mannwhitney
test
use
continu
data
pvalu
consid
statist
signific
number
patient
involv
event
number
patient
hospit
twice
studi
period
mean
patient
age
year
mean
length
hospit
stay
day
event
male
femal
event
occur
exsmok
event
current
smoker
nonsmok
tabl
pathogen
identifi
event
among
event
number
patient
bacteri
identif
viral
identif
bacterialvir
coidentif
identif
respect
among
event
identifi
singl
pathogen
event
identifi
multipl
pathogen
common
bacteri
pathogen
pseudomona
aeruginosa
streptococcu
pneumonia
haemophilu
influenza
staphylococcu
aureu
klebsiella
pneumonia
fig
common
viral
pathogen
influenza
viru
rhinoviru
parainfluenza
viru
metapneumoviru
aecopd
event
sever
copd
stage
iv
predict
valu
sever
copd
stage
iii
predict
valu
moder
copd
stage
ii
predict
valu
mild
copd
stage
predict
valu
advanc
copd
stage
higher
bacteri
identif
rate
tend
p
aeruginosa
pneumonia
show
strongest
associ
p
respect
contrast
viral
identif
rate
tend
lower
advanc
copd
stage
bacteria
virus
show
associ
identif
rate
gold
stage
tabl
aecopd
event
result
patient
death
hospit
case
show
bacteri
pathogen
identif
higher
rate
nonmort
event
contrast
one
case
identifi
viral
pathogen
significantli
lower
nonmort
event
aureu
k
pneumonia
identifi
mortal
event
group
aureu
k
pneumonia
p
aeruginosa
identif
rate
mortal
event
nonmort
event
group
although
differ
statist
signific
bacteria
virus
also
show
signific
differ
identif
rate
mortal
nonmort
event
tabl
three
bacteria
show
season
differ
identif
rate
pvalu
virus
show
season
differ
pvalu
influenza
viru
rhi
noviru
mainli
identifi
winter
parainfluenza
viru
summer
metapneumoviru
spring
fig
event
involv
bacteri
infect
bacterialvir
coidentif
observ
event
involv
viral
infect
bacterialvir
coidentif
observ
bacteria
p
aeruginosa
highest
coidentif
rate
virus
rhinoviru
highest
coidentif
rate
fig
larg
retrospect
populationbas
singl
center
studi
bacteri
viral
pathogen
associ
aecopd
republ
korea
includ
epidemiolog
factor
bacteri
viral
infect
common
caus
aecopd
bacteri
identif
rate
aecopd
event
previous
report
viral
identif
rate
studi
show
similar
result
bacteri
identif
rate
viral
identif
rate
commonli
identifi
bacteria
previou
studi
aecopd
h
influenza
moraxella
catarrhali
pneumonia
howev
studi
catarrhali
identifi
aecopd
event
along
h
influenza
pneumonia
studi
p
aeruginosa
identifi
major
aecopd
pathogen
previou
studi
found
p
aeruginosa
identif
rate
increas
gold
stage
higher
pneumonia
identif
rate
associ
comorbid
result
agre
previou
studi
found
p
aeruginosa
identif
increas
gold
stage
increas
correl
pneumonia
identif
rate
gold
stage
seem
due
high
comorbid
advanc
gold
stage
low
identif
rate
catarrhali
may
due
region
differ
reason
catarrhali
may
cultur
better
bacteria
identif
rate
may
low
new
molecular
diagnost
method
nucleic
acid
amplif
test
antigen
detect
assay
pcr
assay
reveal
import
viral
infect
caus
aecopd
meanwhil
viru
also
identifi
major
caus
exacerb
aecopd
patient
low
creactiv
protein
level
respiratori
viral
infect
affect
epitheli
cell
airway
lead
microvascular
dilat
edema
inflammatori
cell
infiltr
reduct
mucociliari
clearanc
previou
studi
aecopd
rhinoviru
commonli
identifi
viru
studi
influenza
parainfluenza
virus
along
rhinoviru
highest
identif
rate
high
influenza
identif
rate
studi
like
due
influenza
epidem
korea
event
influenza
viru
identif
occur
time
result
suggest
rhinoviru
viru
commonli
identifi
aecopd
unless
anoth
viru
outbreak
mention
p
aeruginosa
frequent
identifi
sever
sever
copd
patient
thought
relat
bronchiectasi
high
preval
bronchiectasi
found
patient
moder
sever
copd
chest
comput
tomographi
perform
event
bronchiectasi
diagnos
event
preval
bronchiectasi
gold
stage
stage
ii
stage
iii
stage
iv
choos
antibiot
use
patient
sever
sever
aecopd
antibiot
antimicrobi
activ
p
aeruginosa
consid
preval
respiratori
virus
close
relat
temperatur
humid
korea
four
distinct
season
worldwid
viral
identif
aecopd
shown
season
variat
studi
influenza
viru
rhinoviru
detect
winter
metapneumoviru
spring
parainfluenza
viru
summer
result
consist
previou
studi
conduct
istanbul
metapneumoviru
promin
spring
parainfluenza
viru
predomin
summer
knowledg
season
viru
preval
help
prevent
treatment
respiratori
viral
infect
aecopd
rate
mortal
due
aecopd
higher
bacteria
identifi
age
comorbid
home
oxygen
use
higher
mortal
group
nonmort
group
therefor
factor
type
infect
basal
condit
patient
taken
consider
predict
prognosi
mortal
coidentif
bacteri
viral
infect
known
infect
occur
first
recent
studi
shown
respiratori
viral
infect
caus
dysregul
iron
homeostasi
mechan
associ
secondari
bacteri
infect
addit
respiratori
syncyti
viru
promot
develop
p
aeruginosa
biofilm
vitro
vivo
hand
bacteri
infect
airway
promot
respiratori
viral
infect
lung
infect
p
aeruginosa
tight
junction
epithelium
damag
result
releas
lactat
dehydrogenas
destroy
lung
barrier
bacteria
studi
p
aeruginosa
commonli
coidentifi
viru
studi
interact
p
aeruginosa
virus
need
studi
limit
first
retrospect
singl
center
studi
therefor
mani
event
exclud
lack
data
exclus
criteria
exampl
evalu
pneumococc
vaccin
find
influenza
vaccin
coverag
patient
thu
could
analyz
effect
influenza
vaccin
time
influenza
epidem
also
chest
comput
tomographi
perform
case
applic
event
second
colon
could
distinguish
analysi
detect
particular
would
advantag
previou
followup
data
sputum
cultur
third
influenza
rapid
antigen
test
perform
event
addit
mainli
perform
epidem
season
think
would
affect
analysi
season
variat
fourth
phenotyp
copd
might
major
impact
pathogen
identif
howev
retrospect
data
difficult
accur
identifi
copd
phenotyp
thu
could
analyz
accord
copd
phenotyp
howev
studi
merit
larg
studi
evalu
bacteri
viral
identif
rate
associ
aecopd
south
korea
provid
inform
help
understand
epidemiolog
aecopd
conclus
bacteri
viral
infect
major
caus
aecopd
preval
identifi
pathogen
region
variabl
studi
commonli
identifi
bacterium
associ
aecopd
p
aeruginosa
commonli
identifi
viru
influenza
catarrhali
show
low
identif
rate
characterist
korea
virus
shown
preval
certain
season
korea
understand
epidemiolog
infect
aecopd
help
select
antibiot
treatment
